AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
AVMA news
In Short - Feb. 15, 2022
Highly pathogenic avian influenza has been found in Canada and the U.S., a resource offers advice on global veterinary careers, a meeting report from…
JAVMA news
Candidate vaccine protects pigs against African swine fever strains
A U.S. Department of Agriculture–developed vaccine against African swine fever protected pigs in a second study, suggesting progress toward a…
JAVMA news
Racing to save humans through animal research
Veterinary researchers are improving our understanding of the SARS-CoV-2 virus, interspecies transmission, and a host of other public and animal…
JAVMA news
Specialists in short supply
The veterinary profession has a shortage of specialists across most or all disciplines,
JAVMA news
ASPCA poison control takes 3 millionth case
The American Society for the Prevention of Cruelty to Animals' Animal Poison Control Center received a call from its 3 millionth client since opening…
JAVMA news
AAHA releases new guidelines on canine vaccination
The American Animal Hospital Association announced Sept. 5 that it has released new guidelines on canine vaccination.
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
Katrina: stories from the storm
A decade has passed since Hurricane Katrina hit New Orleans on Aug. 29, 2005, breaking levees and flooding much of the area.
JAVMA news
Large animal practitioners grapple with fluid shortage
Large animal practitioners are grappling with a shortage of large-volume bags of polyionic fluids, separate from the ongoing shortage
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…